KR

Kevin Rajnikant Shah

Active Director Director DIN 03008805
DIN 03008805 First appointment Dec 2010 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Total affiliations 9 Since Dec 2010
Shareholding value •••• Premium profile

About Kevin Rajnikant Shah

Data last updated:

Kevin Rajnikant Shah is a Director at Advino Healthcare Private Limited (since 2016), Director at Asilia Home Healthcare Private Limited (since 2018) and Director at Zenobio Life Sciences Private Limited (since 2011), and holds 6 more current directorships. The companies operate in Healthcare, Pharma and Financial Services. The 7 current companies with reported revenue have a combined latest revenue of ₹20.29 Cr; the largest is Advino Healthcare Private Limited at ₹11.36 Cr (FY 2024).

DIN 03008805
Primary Designation Director
Industry Healthcare
First Appointment 15 Dec 2010
Oldest Company Age 48 yrs
Largest company Advino Healthcare Private Limited · ₹11.36 Cr (FY 2024)
Combined revenue ₹20.29 Cr across 7 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Advino Healthcare Private Limited U33119GJ2016PTC092215
Director27 May 20162016₹11.36 Cr (FY 2024)Active
Director01 Apr 20182014₹5.68 Cr (FY 2023)Active
Director01 Sep 20111977₹2.61 Cr (FY 2024)Active
Kevin Realtors Private Limited U45201GJ1998PTC034192
Director15 Dec 20101998₹63.6 Lakh (FY 2025)Active
Satvam Chemicals Private Limited U24290RJ2023PTC085815
Director11 Jan 20232023₹3,000 (FY 2025)Active
Samast Chemicals Private Limited U24304TG2023PTC170532
Director18 Jan 20232023₹2,650 (FY 2025)Active
Unita Chemicals Private Limited U24290MH2023PTC396601
Director03 Jan 20232023₹1,810 (FY 2025)Active
Designated Partner20 Mar 20202020Active

Directorship timeline

Open interactive timeline →
Aurshine Jewels Llp
Advino Technologies Llp
Advino Healthcare Private Limited
Zenobio Life Sciences Private Limited
Premium access

Shareholding and investment profile for Kevin Rajnikant Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kevin Rajnikant Shah

Kevin Rajnikant Shah currently holds 9 directorships: Advino Healthcare Private Limited (Director, since 27 May 2016, revenue ₹11.36 Cr (FY 2024)); Asilia Home Healthcare Private Limited (Director, since 01 Apr 2018, revenue ₹5.68 Cr (FY 2023)); Zenobio Life Sciences Private Limited (Director, since 01 Sep 2011, revenue ₹2.61 Cr (FY 2024)); Kevin Realtors Private Limited (Director, since 15 Dec 2010, revenue ₹63.6 Lakh (FY 2025)); Satvam Chemicals Private Limited (Director, since 11 Jan 2023, revenue ₹3,000 (FY 2025)); and 4 more.

Kevin Rajnikant Shah was first appointed on 15 Dec 2010 as Director at Kevin Realtors Private Limited. The most recent appointment on record is 18 Jan 2023 at Samast Chemicals Private Limited.

The 7 current companies of Kevin Rajnikant Shah that report revenue have a combined latest revenue of ₹20.29 Cr: Advino Healthcare Private Limited ₹11.36 Cr (FY 2024); Asilia Home Healthcare Private Limited ₹5.68 Cr (FY 2023); Zenobio Life Sciences Private Limited ₹2.61 Cr (FY 2024); Kevin Realtors Private Limited ₹63.6 Lakh (FY 2025); Satvam Chemicals Private Limited ₹3,000 (FY 2025); and 2 more.

The current boards of Kevin Rajnikant Shah's companies include Savani Odhavjibhai Dharmesh (Advino Healthcare Private Limited), Mrunal Kantibhai Prajapati (Zenobio Life Sciences Private Limited), Sachin Motibhai Prajapati (Zenobio Life Sciences Private Limited), Ramesh Arjanbhai Marand (Kevin Realtors Private Limited), Sweni Shah (Kevin Realtors Private Limited), Ajay Nyalchandbhai Sanghvi (Satvam Chemicals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available